Back to search
FDAFDA · Food and drugs·Recall number Z-2167-2018

The VITEK® 2 Gram Positive Susceptibility Card is intended for use with the VITEK 2 Systems in clinical laboratories as an in vitro test to determine the susceptibility of Staphylococcus spp., Enterococcus spp., and S. agalactiae to antimicrobial agents. Fully automated short-term incubation cycle antimicrobial susceptibility system is a device that incorporates concentrations of antimicrobial agents into a system for the purpose of determining in vitro susceptibility of bacterial pathogens isolated from clinical specimens. Test results obtained from short-term (less than 16 hours) incubation are used to determine the antimicrobial agent of choice to treat bacterial diseases.

Published June 20, 2018 · Recall initiated: March 23, 2018

Summary

FDA records medical device Class II recall Z-2167-2018, published June 20, 2018 and initiated March 23, 2018. Recalling firm: BioMerieux SA; Status: Terminated; Reported quantity: 5 boxes with AST-P606 TEST KIT 20 CARDS; Lot: VITEK® 2 AST-P606 (ref: 22330): Lot Number 4860117403. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

A shipment to Guadeloupe suffered a temperature excursions up to 47.8®C, exceeding the acceptable limits. After detection of the issue, Global Supply Chain QA asked the bioM®rieux distributor in Guadeloupe to put products in quarantine in July 2017; After several reminders, the distributor informed in November 2017 that products were delivered to customers.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
BioMerieux SA
Distributor
International distribution.
Lot
VITEK® 2 AST-P606 (ref: 22330): Lot Number 4860117403
Risk classification
Class II
Area (FDA)
device
Country
France

Related recalls

Questions about this recall

Was The VITEK® 2 Gram Positive Susceptibility Card is intended for use with the VITEK 2 Systems in clinical laboratories as an in vitro test to determine the susceptibility of Staphylococcus spp., Enterococcus spp., and S. agalactiae to antimicrobial agents. Fully automated short-term incubation cycle antimicrobial susceptibility system is a device that incorporates concentrations of antimicrobial agents into a system for the purpose of determining in vitro susceptibility of bacterial pathogens isolated from clinical specimens. Test results obtained from short-term (less than 16 hours) incubation are used to determine the antimicrobial agent of choice to treat bacterial diseases. recalled?

Yes. FDA published recall Z-2167-2018 on June 20, 2018. Reported hazard: A shipment to Guadeloupe suffered a temperature excursions up to 47.8®C, exceeding the acceptable limits. After detection of the issue, Global Supply Chain QA asked the bioM®rieux distributor in Guadeloupe to put products in quarantine in July 2017; After several reminders, the distributor informed in November 2017 that products were delivered to customers.

What should I do if I have this product?

Voluntary: Firm initiated · Letter